Navigation Links
IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring
Date:8/21/2009

WINTER PARK, Fla., Aug. 17 /PRNewswire/ -- The United States Food and Drug Administration has granted IRadimed Corporation clearance of its new MRidium 3860+ MRI Infusion System with integrated Masimo SET(R) SpO2 Monitoring. Transport to the MRI for Sedation, Critical Care, and Cardiac Patients to date has required multiple pieces of equipment, with hospital infusion pumps and SpO2 being typically not designed to be integrated and functional in the MRI. Clinicians no longer have to remember each time when they get to the door of the MRI to remove their standard hospital SpO2 equipment so that it does not become a dangerous projectile, or risk a patient burn, in the MR environment. IRadimed has innovatively combined two critically needed technologies for the MRI to increase productivity, patient safety, and ease of transport to, from, and within the MRI.

The Innovative MRidium(TM) 3860+ MRI Infusion System is the first Non-Magnetic IV Pump designed specifically for use in the MRI Environment with Integrated Masimo SET(R) technology. "We chose the Masimo SET(R) technology because it has such an excellent reputation in the marketplace. Masimo's systems are viewed by most as one of the best monitoring technologies in the world," said Todd Weber, VP Sales and Marketing. Safety in the MR is the primary concern when it comes to meeting needs for required patient care. These risks are all well-known, as essential IV and monitoring equipment can: fly into the bore, cause artifacts on the images, become unreliable during crucial deliveries of medications and monitoring, or shut down completely when needed the most. Use of improper pulse oximeters has caused severe burns to patients due to the high RF fields involved within MR scanners. "It is critical to have products which have been designed with the utmost care and thorough insight of this harsh and potentially dangerous environment," said Roger Susi, founder of IRadimed Corporation.

In hospitals all around the globe, the patient population going to the MRI is growing every day. Today, more and more hospitals are eliminating the long IV lines under their MR Scanner Room doors. Recent studies indicate the addition of 15 to 30 feet of IV Extension Sets significantly reduces the alarm times of syringe and IV pumps, making delivery of critical medications risky at best. Patients are coming to MRI with more IV lines and new types of cases, such as stressing the heart, inter-operative procedures, brain lab suites, cancer patients, and sedations, with many of these patients needing accurate delivery at lower rates and volumes. The MRidium(TM) System has been designed to meet these changing needs by reducing the risk; there is no need for long IV lines or Syringe pumps placed outside the Magnet Room. No need to remember to remove the standard hospital SpO2 Monitor, because the MRidium(TM) Pump has the ability to maneuver right next to the bore of the MRI and deliver medications safely and efficiently. All while being monitored through its wireless remote control, which operates inside the MRI control room.

The MRidium(TM) Pump has the ability to work at the 10,000 Gauss magnetic field environment of 1.5 and 3.0 Tesla MR Scanners, and the system includes the remote control ability for adjusting critical medication deliveries and alarm monitoring from outside the MR Scanner room. The safe placement of the pump is of the utmost importance, because these safety-critical Gauss line limits are invisible and different for every magnet design and strength, which makes it difficult to know where the safe limits are in relation to the MR Scanner. The 10,000 Gauss Line is virtually inside the bore of the MR Scanner in many cases, which allows the use of the MRidium(TM) Pump in close proximity to the MR scanner.

The MRidium(TM) System's remote ability allows clinicians to monitor the infusion progress and make changes to the pump from outside the MR scanner room without having to stop the scan; this provides the ability to adjust or bolus critical medications, such as Propofol, which is commonly used for MR Anesthesia, without interrupting, or unnecessarily delaying, the MR scan.

The New MRidium(TM) 3860+ System has a number of key new features which make this MR IV Pump simple and safe to deliver even the smallest of infusions. With rate ranges from 0.1 ml to 1400 ml per hour, the MRidium(TM) System is designed to meet all of your infusion needs. The new 10-digit keypad makes programming a snap, with quick changes at the press of a few buttons. This Smart Infusion System also has an integrated programmable drug library designed for the MRI - making it an indispensable tool for delivery of critical medications such as Dobutamine, Adenosine, Propofol, and Dexmedetomidine. The system also offers a modular second channel which allows for delivery of two medications simultaneously during patient scans. A range of available infusion sets provides the necessary clinical flexibility needed for MRI Infusion. The MRidium(TM) 1055 Bypass Infusion set allows clinicians to quickly change over IV sets from the hospital-based infusion system without having to disconnect the lines from the patient. The MRidium(TM) 1057 Vented Syringe Adapter Set allows for accurate delivery from a syringe using a low priming volume of only 4 milliliters per set.

The MRidium(TM) 3860+ MRI IV Pump with Integrated Masimo SET(R) SpO2 Technology is marketed globally through one of their many distributors. To request a demonstration, please contact sales@iradimed.com or call: 1-407-677-8022 and ask for the sales department.

About IRadimed Corporation

IRadimed Corporation has vast experience in MRI safe products and Infusion Therapy. Our founder is the pioneering developer of the world's first and best-selling MRI-compatible monitoring system. Our staff has a combined 60+ years developing MRI-safe products. The MRidium(TM) Infusion System has full benefit of the experience and attention to details so important to the development of quality equipment which can be safely used in the MRI setting.

http://www.iradimed.com

MRidium(TM) is a Trademark of IRadimed Corporation

Masimo(R) and Masimo SET(R) are registered trademarks of Masimo Corporation.

    Contact:

    Todd Weber
    Vice President Sales and Marketing
    IRadimed Corporation
    407-677-8022 Ext. 112
    tweber@iradimed.com

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE IRadimed Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nihon LocalSoft Designs New Japanese Software for IRadimed Corporations Award-Winning MRidium MRI Infusion System
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... Each year Standard Process Inc. ... is this year’s Life University winner of a $2,500 scholarship from ... Leadership Awards ceremony. , Outerbridge is approaching her last quarter at Life University ...
(Date:5/26/2016)... ... ... last week’s media reports hinting at a June rate hike after the Federal Reserve’s ... interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at Georgia ... (FOMC) dot charts are of interest to the press for their noise potential,” Dhawan ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ., ... with a 2016 When Work Works Award for its use of effective workplace strategies ... When Work Works project administered by the Families and Work Institute (FWI) and the ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Chicago, Illinois (PRWEB) , ... May 26, 2016 , ... ... relationship with women’s basketball as a partner for the Tamika Catchings Legacy Tour ... , As the industry leader in hardwood basketball surfaces in all forms and levels ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment of ... doses of biotin in progressive multiple sclerosis: extension phase results ... Ayman Tourbah , Principal Investigator of the Phase 3 study, ... (EAN) in Copenhagen, Denmark . The oral ... Sunday, 29 May 2016 from 14:45 to 16:15 CEST in ...
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
Breaking Medicine Technology: